Tamer I Khayal sold $252K of TransMedics (TMDX)

Executed Oct 1 2024, disclosed Oct 3 2024, 2 days later.

Value, as filed

$252K

1,723 sh across 2 lots

Executed

Oct 1 2024

the trade date, as filed

Disclosed

Oct 3 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TK Tamer I Khayal Chief Commercial Officer profile →

Tamer I Khayal (Chief Commercial Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in TransMedics Group, Inc. (TMDX). The largest single filing was $252K of TMDX (1,723 sh across 2 lots, as filed), executed Oct 1 2024.

The name

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Tamer I Khayal in TMDX

TMDXSALE TransMedics Group, Inc. $184K
2,407 sh × $76.43
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET TMDXSALE TransMedics Group, Inc. $131K
1,458 sh × $90.04
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET